Reading the Blueprint: Diagnosis and Your Lab Reports

Navigating the diagnostic journey for RAC2-related immunodeficiency often involves a complex trail of blood tests and genetic sequencing. Because this condition is so rare, your laboratory reports may contain specialized terms that are not common in routine medical care. Understanding these results is essential for determining which part of the immune system needs the most support.

Common Findings on Immune Lab Reports

While every person’s experience with RAC2 is unique, certain patterns often emerge in laboratory results. These tests look at both the number of immune cells and how well they “see” and fight germs ^[1].

Lymphocyte Subsets and Output

Lymphocytes (T cells, B cells, and NK cells) are often affected by RAC2 mutations.

• Lymphopenia: This is a low count of lymphocytes in the blood ^[1].
• TREC and KREC: These tests are indirect measures of new immune cells being made by the body. TREC (T-cell Receptor Excision Circles) measures new T cells from the thymus, while KREC (Kappa-recombining Excision Circles) measures new B cells from the bone marrow ^[2]. Low levels require interpretation alongside absolute lymphocyte subsets and clinical findings, as they are age-, illness-, and treatment-dependent ^[3][4].
• Naïve vs. Memory Cells: Lab reports may break down T cells into “naïve” (cells that haven’t fought an infection yet) and “memory” (cells that remember past germs). Some RAC2 patients have fewer naïve cells, making it harder for the body to respond to new viruses ^[4].

Immunoglobulin (Antibody) Levels

Antibodies, also called immunoglobulins (IgG, IgA, IgM), are proteins that “tag” germs for destruction. In RAC2 disease, these levels are variable ^[1].

• Some patients have low IgG (the most common antibody) ^[3].
• Others may have low IgM but high IgA or IgE ^[5].
• Because these levels can change, your doctor will likely monitor them over time to see if your body is still making enough protective antibodies.

Why Protein Testing Isn’t Enough

If you have a genetic condition, it might seem logical to test if the protein is “there.” However, testing for RAC2 protein expression (how much protein is present) can be very misleading ^[1].

In some cases, a patient may have a normal or even a high amount of RAC2 protein, but the protein is stuck in the “on” or “off” position and doesn’t work ^[3]. Conversely, some patients have very little protein, but the small amount they have is hyperactive and causes over-signaling ^[6]. Because the amount doesn’t tell the whole story, doctors must use functional assays—tests that watch the protein’s activity.

Essential Functional Tests

To get a complete picture, your medical team should look at how your cells move and react. Key functional tests include:

• DHR-123 (Oxidative Burst): This test measures the reactive oxygen species that neutrophils use to kill bacteria ^[7]. Neutrophil oxidative-burst results can vary by variant and assay; in some RAC2 mutations, this burst is too weak, while in others it may be elevated ^[3][4].
• Actin Polymerization/Polarization: This looks at how well a cell can reshape its internal “skeleton” (actin) to move toward an infection ^[3].
• Chemotaxis: This measures the “crawling” speed and direction of your white blood cells. Note that a leukocyte-migration defect can occur even with a normal or elevated overall neutrophil count ^[1][8].

Advanced Specialist Evaluation

A thorough diagnostic workup for RAC2 typically includes genetic sequencing and standard clinical tests. An expert immunology center may consider the following advanced tests when a genetic finding (like a VUS) or the phenotype needs clarification:

1. Genetic Sequencing: Usually Whole Exome Sequencing (WES) or a targeted primary immunodeficiency panel ^[9].
2. Complete Blood Count (CBC) with Differential: To check for neutropenia (low neutrophils) or lymphopenia ^[10].
3. Lymphocyte Subsets: A detailed count of T, B, and NK cells, including naïve and memory markers ^[10].
4. Quantitative Immunoglobulins: Testing IgG, IgA, IgM, and sometimes IgE levels ^[9].
5. Vaccine Response Titer: Checking if your body produced antibodies to vaccines (though difficult to interpret if already on immunoglobulin therapy) ^[10].
6. Neutrophil Functional Testing: Specifically the DHR-123 oxidative burst assay and migration/crawling studies ^[1][7].
7. Advanced Signaling Assays: Specialist tests (often done in research labs) that measure PAK1 binding or AKT phosphorylation to see how the “molecular switch” is behaving ^[1][11].

No single functional assay alone confirms or excludes the disease.